Brecelj J, Orel R. Non-alcoholic fatty liver disease in children. Medicina (Kaunas). 2021;57(7):719.

Article  PubMed  PubMed Central  Google Scholar 

Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int. 2017;37(Suppl. 1):85–9.

Article  PubMed  Google Scholar 

Goyal NP, Schwimmer JB. The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin Liver Dis. 2016;20(2):325–38.

Article  PubMed  Google Scholar 

Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: recent solutions, unresolved issues, and future research directions. World J Gastroenterol. 2016;22(36):8078–93.

Article  PubMed  PubMed Central  Google Scholar 

Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from “two hit theory” to “multiple hit model.” World J Gastroenterol. 2018;24(27):2974–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergheim I, Moreno-Navarrete JM. The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease. Eur J Clin Invest. 2024;54(7):e14224.

Article  CAS  PubMed  Google Scholar 

Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319–34.

Article  PubMed  PubMed Central  Google Scholar 

Lee JH, Lee HS, Ahn SB, Kwon YJ. Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease. Clin Nutr. 2021;40(10):5252–60.

Article  CAS  PubMed  Google Scholar 

Hong R, Xie A, Jiang C, Guo Y, Zhang Y, Chen J, et al. A review of the biological activities of lactoferrin: mechanisms and potential applications. Food Funct. 2024;15(16):8182–99.

Article  CAS  PubMed  Google Scholar 

Hassan MA, Abedelmaksoud TG, Abd El-Maksoud AA. Effects of lactoferrin supplemented with fermented milk on obesity-associated pancreatic damage in rats. Life. 2022;12(12):201.

Article  Google Scholar 

Zapata RC, Singh A, Pezeshki A, Nibber T, Chelikani PK. Whey protein components—lactalbumin and lactoferrin—improve energy balance and metabolism. Sci Rep. 2017;7(1):9917.

Article  PubMed  PubMed Central  Google Scholar 

Liu ZS, Chen PW. Featured prebiotic agent: the roles and mechanisms of direct and indirect prebiotic activities of lactoferrin and its application in disease control. Nutrients. 2023;15(12):2759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo C, Xue H, Guo T, Zhang W, Xuan WQ, Ren YT, et al. Recombinant human lactoferrin attenuates the progression of hepatosteatosis and hepatocellular death by regulating iron and lipid homeostasis in ob/ob mice. Food Funct. 2020;11(8):7183–96.

Article  CAS  PubMed  Google Scholar 

Wu JX, He Q, Zhou Y, Xu JY, Zhang Z, Chen CL, et al. Protective effect and mechanism of lactoferrin combined with hypoxia against high-fat diet induced obesity and non-alcoholic fatty liver disease in mice. Int J Biol Macromol. 2023;227:839–50.

Article  CAS  PubMed  Google Scholar 

Ding L, Chen JS, Xing YF, Li DM, Fu AQ, Tong X, et al. Effects of lactoferrin on high-fat and high-cholesterol diet-induced non-alcoholic fatty liver disease in mice. J Nutr Biochem. 2025;143:109938.

Article  CAS  PubMed  Google Scholar 

Ono T, Murakoshi M, Suzuki N, Iida N, Ohdera M, Iigo M, et al. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 2010;104(11):1688–95.

Article  CAS  PubMed  Google Scholar 

Jańczuk-Grabowska A, Czernecki T, Brodziak A. Gene-diet interactions: viability of lactoferrin-fortified yoghurt as an element of diet therapy in patients predisposed to overweight and obesity. Foods. 2023;12(15):2929.

Article  PubMed  PubMed Central  Google Scholar 

Mohamed WA, Schaalan MF. Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway. Diabetol Metab Syndr. 2018;10:89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J. 2000;320(7244):1240–3.

Article  CAS  Google Scholar 

El-Hawy MA, Abd Al-Salam SA, Bahbah WA. Comparing oral iron bisglycinate chelate, lactoferrin, lactoferrin with iron and iron polymaltose complex in the treatment of children with iron deficiency anemia. Clin Nutr ESPEN. 2021;46:367–71.

Article  PubMed  Google Scholar 

Tsukahara T, Fujimori A, Misawa Y, Oda H, Yamauchi K, Abe F, et al. The preventive effect of lactoferrin-containing yogurt on gastroenteritis in nursery school children: intervention study for 15 weeks. Int J Environ Res Public Health. 2020;17(7):2534.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Amrousy D, El-Afify D, Elsawy A, Elsheikh M, Donia A, Nassar M. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial. Pediatr Res. 2022;92(3):762–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hegazy SK, Koura MS, Elharoun MS. Oral lactoferrin as a treatment of pediatrics’ anemia resulted from chronic kidney diseases: a randomized controlled trial. Sci Rep. 2025;15(1):4380.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.5.

Article  CAS  PubMed  Google Scholar 

Draper H, Hadly M. Malonaldehyde determination as an index of lipid peroxidation. Methods Enzymol. 1990;186:421–31.

Article  CAS  PubMed  Google Scholar 

Boyraz M, Pirgon Ö, Dündar B, Çekmez F, Hatipoğlu N. Long-term treatment with n-3 polyunsaturated fatty acids as a monotherapy in children with nonalcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2015;7(2):121–7.

Article  PubMed  PubMed Central  Google Scholar 

Maekawa Y, Sugiyama A, Takeuchi T. Lactoferrin potentially facilitates glucose regulation and enhances the incretin effect. Biochem Cell Biol. 2017;95(1):155–61.

Article  CAS  PubMed  Google Scholar 

Pal S, Ellis V, Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br J Nutr. 2010;104(5):716–23.

Article  CAS  PubMed  Google Scholar 

Moreno-Navarrete JM, Ortega FJ, Bassols J, Ricart W, Fernández-Real JM. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab. 2009;94(10):4036–44.

Article  CAS  PubMed  Google Scholar 

Du Y, Li D, Chen J, Li YH, Zhang Z, Hidayat K, et al. Lactoferrin improves hepatic insulin resistance and pancreatic dysfunction in high-fat diet and streptozotocin-induced diabetic mice. Nutr Res. 2022;103:47–58.

Article  CAS  PubMed